The clinical study of propofol potential dependence and its possible high risks in gastric endoscopy patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17010581

Enrollment

Unknown

Registered

2017-02-08

Start date

2017-02-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug dependence

Interventions

propofol group:propofol

etomidate group:etomidate

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients who were prepared for gastrointestinal endoscopy. 2.ASA I-II level, excluding anesthesia taboo. 3. Patients are able to understand the entire course of the clinical study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, lung, brain and other major organ diseases. 2. Persons with mental and verbal communication disabilities. 3. History of drug abuse, history of dependence and history of drug allergy. 4. Participating in other clinical trials of patients. 5. The researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

Measure	Time frame
Pentobarbital-Chlorpromazine-Alcohol Group score;Morphine-Benzedrine Group score;	—

Secondary

Measure	Time frame
Sleep quality score;Anxiety score;Depression score;	—

Countries

China

Contacts

Public ContactQuan Li

Shanghai East Hospital

quanligene@126.com+86 13816262446

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026